🔴 $ROIV — Epperly Melissa B,, Director
SOLD: 16,850 shares @ $36.08
Total: $608K
Filed Sep 30, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/ROIV

#InsiderTrading #ROIV #StockMarket

🔴 $ROIV — Venker Eric, President & Immunovant CEO
SOLD: 200,000 shares @ $36.62
Total: $7.3M
Filed Sep 29, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/ROIV

#InsiderTrading #ROIV #StockMarket

📄 $ROIV 10-Q — what changed
MD&A now says: "The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our (1) unaudited condensed consolidated financial statements and notes to those statements included in this Quarterly Report on

🔴 $ROIV — Fitzgerald Meghan, Director
SOLD: 4,712 shares @ $39.68
Total: $187K
Filed Sep 14, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/ROIV

#InsiderTrading #ROIV #StockMarket

🔴 $ROIV — Epperly Melissa B,, Director
SOLD: 4,338 shares @ $39.65
Total: $172K
Filed Sep 14, 2026 · 8:00pm ET
📈 History & trend → https://www.formdelta.com/ticker/ROIV

#InsiderTrading #ROIV #StockMarket

Anomalous Activity for Sep 8: $ROIV
$ROIV is a standout cross-sectional outlier today: Capital Flow +4.1σ, Relative Return +7.7σ, Relative Gap +9.7σ. History was quiet into today, so this reads as a sudden regime shift rather than a persistent trend.

Anomaly Analysis for Sep 8:
Cross-sectional dispersion is elevated and concentrated in equities. $ROIV leads with Relative Return +7.7σ and Relative Gap +9.7σ, while $NVS and $AMGN pair extreme Capital Flow with weak Relative Return. $MPC extends persistent positive Persistence.